Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
LENZ
LENZ Therapeutics, Inc.
NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close
$3.84
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap
$120.65M
Country
USA
RECENT INSIDER TRADES
2026-03-30
· Chevallard Daniel R.
(Chief Financial Officer)
· BUY
2026-03-30
· George Jeffrey P.
(Director)
· BUY
2026-03-30
· Schimmelpennink Evert B.
(President, CEO and Secretary)
· BUY
2025-11-19
· Olsson Shawn
(Chief Commercial Officer)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
154
Shares held
37,194,331
Value
$232.47M
Percent of shares outstanding
118.38%
As of quarter end
2026-06-30
RECENT NEWS
LENZ Therapeutics: Below Cash For A Reason
LENZ: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
LENZ: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
LENZ Therapeutics, Inc. (LENZ) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit